Effectiveness, Safety and Tolerability Study of RP-G28 for Symptoms Associated With Lactose Intolerance
Clinical trial NCT01113619 · COMPLETED
Trial details
- NCT number
- NCT01113619
- Sponsor
- Ritter Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2011-10-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.